tobramycin · Viatris · NDA 201688
Tobi Podhaler
Earliest generic entry, as listed
4 Nov 2030
Blocked by patent: US 10207066.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10207066 | product, use U-909 | 4 Nov 2030 |
| US 8869794 | product, use U-909 | 12 Sep 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 201688 · 001 · RLD | powder, inhalation | 28MG | 4 Nov 2030 |